The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The popular heart drug valsartan may have been contaminated with carcinogen NDMA for as long as four years before anyone discovered the problem. We’re not talking a small contamination, either. The pills contained as much as 177 times the level of NDMA deemed safe for human consumption, and dozens of manufacturers have used it as an ingredient. Today, about 50 patients so far have filed lawsuits against drug manufacturers, claiming they contracted cancer by using the medication. Lawyers expect to file even more suits.

At a hearing last month, attorneys estimated that 1.5 million people in the U.S. took contaminated valsartan in 2018.

Valsartan Recall and Mounting Litigation

The FDA has been coordinating a valsartan recall since July 2018, which is when NDMA was discovered in the medicine manufactured by Zhejiang Huahai Pharmaceutical Co. The contaminated valsartan was sold to a number of major drugmakers, who then used it as an ingredient in medications for high blood pressure, heart failure and other conditions. Millions of Americans use these drugs, many of whom are elderly patients.

In addition to Zhejiang Huahai and its affiliates, nearly 40 other named defendants in the lawsuits include Teva Pharmaceutical Industries Ltd., Mylan NV, and CVS Health Corp.

For more information on the recall and valsartan litigation, visit the informational page by TorHoerman Law here.

After Litigation, Plaintiffs Should Properly Plan for Settlement

Settlement planning for elderly clients with cancer takes special care. Preserving Medicaid and receiving a settlement can be a challenge for any family. Milestone Consulting has guided thousands of people through the settlement process by taking the time to understand the complexities of each case, assessing the best outcome, and finding the paths that allow plaintiffs to manage their many needs. Feel free to call us for advice.

Comments for this article are closed, but you may still contact the author privately.